Overview

Antiviral Drugs on the Treatment of SARS-CoV-2

Status:
Recruiting
Trial end date:
2021-12-25
Target enrollment:
Participant gender:
Summary
Retrospective Non-Randomized Analytical Cohort Study of Completed SARS-CoV2 COVID19 Cases
Details
Lead Sponsor:
Astana Medical University
Treatments:
Favipiravir
Remdesivir